Vitamin D – old substance in new perspectives

Authors: Vladimír Kojecký
Authors‘ workplace: Interní klinika, Krajská nemocnice T. Bati, a. s., Zlín, přednosta MUDr. Jiří Latta
Published in: Vnitř Lék 2015; 61(7-8): 695-697
Category: Vanýsek´s day 2015


Receptors for vitamin D are present almost in all body tissues. Vitamin D does not only act as a regulator of calcium and phosphorus metabolism, but also a substance which modulates the immunity system function, regulates cell proliferation. Genetic, epidemiological and experimental data indicate a possible role of vitamin D deficiency in the development of some diseases, mainly of autoimmune diseases and tumours. The benefit of curative intake of vitamin D has so far not been proven. There is no reason why the deficiency of vitamin D should not be covered. The substitution should start with the replenishment of the lacking amount of vitamin D (which may even be several hundred thousand units) and involve ongoing intake of the recommended substitution dose of 800–1 000 vitamin D units per day.

Key words:
autoimmune disease – vitamin D – intestinal inflammation


1. Krista M, Reich KM, Fedorak RM et al. Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review. World J Gastroenterol 2014; 20(17): 4934–4947.

2. Yasmin R, Williams RM, Xu M et al. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J Biol Chem 2005; 280(48): 40152–40160.

3. Khalili H, Huang ES, Ananthakrishnan AN et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012; 61(12): 1686–1692.

4. Cantorna MT, Zhu Y, Froicu M et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the imune system. Am J Clin Nutr 2004; 80(6 Suppl): S1717-S1720.

5. Ananthakrishnan AN, Khalili H, Higuchi LM et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology 2012; 142(3): 482–489.

6. Ananthakrishnan AN, Cagan A, Gainer VS et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease. Inflamm Bowel Dis 2013; 19(9): 1921–1927.

7. van der Mei IA, Ponsonby AL, Dwyer T et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003; 327 (7410): 316–321.

8. Martineau AR, Mac Laughlin BD, Hooper RL et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 2015; 70(5):451–457. Dostupné z DOI: <–206449>.

9. Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int 2014; 13(6): 580–585.

10. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005; 16(2): 83–95.

11. Wactawski-Wende J, Kotchen JM, Anderson GL et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354(7): 684–696.

12. Avenell A, MacLennan GS, Jenkinson DJ et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 2012; 97(2): 614–622.

13. van Groningen L, Opdenoordt S, van Sorge A et al. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur J Endocrinol 2010; 162(4): 805–811.

Diabetology Endocrinology Internal medicine

Article was published in

Internal Medicine

Issue 7-8

2015 Issue 7-8

Most read in this issue

This topic is also in:

Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account